Endolymphatic delivery of IL2 in patients with melanoma and lymphoma D. W. GalvaniI. S. WaltonR. A. Sells OriginalPaper Pages: 251 - 255
Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer Kiyotaka OkunoHiroaki OhnishiMasayuki Yasutomi OriginalPaper Pages: 257 - 265
Inhibition of proliferation of retrovirus-immortalized macrophages by LPS and IFN-γ: Possible autocrine down-regulation of cell growth by induction of IL1 and TNF Emira AyroldiElisabetta BlasiRobert H. Wiltrout OriginalPaper Pages: 267 - 276
Effect of a 12 HZ and of a 460 HZ pulsed magnetic field on the weight of AKR mice A. Bellossi OriginalPaper Pages: 277 - 283
Asparagine-linked sugar chains of plasma membrane glycoproteins from healthy and common variable immunodeficiency B lymphoblastoid cell lines Naomi KondoFumiaki MotoyoshiTadao Orii OriginalPaper Pages: 285 - 288
Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: A pilot study Johanna W. BaarsJohanna C. M. FonkJohn Wagstaff OriginalPaper Pages: 289 - 297
Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis Kimio NishimuraShigeaki IshizakaTadasu Tsujii OriginalPaper Pages: 299 - 306
The M20 IL-1 inhibitor prevents onset of adjuvant arthritis Barak VivianPeritt DavidTreves Abraham J. OriginalPaper Pages: 317 - 323